Cancer Biomarker Market Size, Share & Trends Report

Cancer Biomarker Market Size, Share & Trends Analysis Report By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2018 - 2025

Report ID: GVR-1-68038-862-6
Number of Pages: 85
Format: Electronic (PDF)

Historical Range: 2014 - 2016
Industry:Healthcare

Market Segmentation

Cancer Biomarkers Type Outlook (Revenue, USD Billion, 2014 - 2025)
- Breast cancer
- Prostate cancer
- Colorectal cancer
- Cervical cancer
- Liver cancer
- Lung cancer
- Others
Cancer Biomarkers Biomolecule Outlook (Revenue, USD Billion, 2014 - 2025)
- Genetic Biomarkers
- Epigenetic Biomarkers
- Metabolic Biomarkers
- Proteomic Biomarkers
- Others
Cancer Biomarkers Application Outlook (Revenue, USD Billion, 2014 - 2025)
- Drug discovery and Development
- Diagnostics
- Personalized medicine
- Others
Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
  - The U.S.
    - The U.S. Cancer biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - The U.S. Cancer biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - The U.S. Cancer biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
  - Canada
    - Canada Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - Canada Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - Canada Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
- Europe
  - UK
    - UK Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - UK Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - UK Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
  - Germany
    - Germany Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - Germany Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - Germany Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
- Asia Pacific
  - Japan
    - Japan Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - Japan Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - Japan Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
  - China
    - China Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - China Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - China Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
  - India
    - India Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - India Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - India Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
- Latin America
  - Brazil
    - Brazil Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - Brazil Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - Brazil Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
  - Mexico
    - Mexico Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - Mexico Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - Mexico Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others
- MEA
  - South Africa
    - South Africa Cancer Biomarkers Market, by Type (USD Billion), 2014 - 2025
      - Breast cancer
      - Prostate cancer
      - Colorectal cancer
      - Cervical cancer
      - Liver cancer
      - Lung cancer
      - Others
    - South Africa Cancer Biomarkers Market, by Biomolecule (USD Billion), 2014 - 2025
      - Genetic Biomarkers
      - Epigenetic Biomarkers
      - Metabolic Biomarkers
      - Proteomic Biomarkers
      - Others
    - South Africa Cancer Biomarkers Market, by Application (USD Billion), 2014 - 2025
      - Drug discovery and Development
      - Diagnostics
      - Personalized medicine
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
Company financial performance

GET A FREE SAMPLE

这个免费样品包括市场数据点,响了ing from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.